These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18403726)

  • 1. Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis.
    Dong B; Zhang C; Feng JB; Zhao YX; Li SY; Yang YP; Dong QL; Deng BP; Zhu L; Yu QT; Liu CX; Liu B; Pan CM; Song HD; Zhang MX; Zhang Y
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1270-6. PubMed ID: 18403726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overexpression of angiotensin converting enzyme 2 inhibits inflammatory response of atherosclerotic plaques in hypercholesterolemic rabbits].
    Dong B; Zhang YH; Dong QL; Yu QT; Zhu L; Li SY; Yang YP; Zhang C; Feng JB; Liu CX; Song HD; Pan CM; Zhang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):622-5. PubMed ID: 19961735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
    Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
    Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-κB pathways.
    Li Y; Cao Y; Zeng Z; Liang M; Xue Y; Xi C; Zhou M; Jiang W
    Sci Rep; 2015 Feb; 5():8209. PubMed ID: 25644821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
    Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between TGF-β and ACE2-Ang-(1-7)-Mas pathway in high glucose-cultured NRK-52E cells.
    Chou CH; Chuang LY; Lu CY; Guh JY
    Mol Cell Endocrinol; 2013 Feb; 366(1):21-30. PubMed ID: 23174757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response.
    Zhang YH; Zhang YH; Dong XF; Hao QQ; Zhou XM; Yu QT; Li SY; Chen X; Tengbeh AF; Dong B; Zhang Y
    Inflamm Res; 2015 Apr; 64(3-4):253-60. PubMed ID: 25721616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages.
    Guo YJ; Li WH; Wu R; Xie Q; Cui LQ
    Arch Med Res; 2008 Feb; 39(2):149-54. PubMed ID: 18164957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.
    Lovren F; Pan Y; Quan A; Teoh H; Wang G; Shukla PC; Levitt KS; Oudit GY; Al-Omran M; Stewart DJ; Slutsky AS; Peterson MD; Backx PH; Penninger JM; Verma S
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1377-84. PubMed ID: 18660448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
    Thatcher SE; Zhang X; Howatt DA; Lu H; Gurley SB; Daugherty A; Cassis LA
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):758-65. PubMed ID: 21252069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function.
    Rentzsch B; Todiras M; Iliescu R; Popova E; Campos LA; Oliveira ML; Baltatu OC; Santos RA; Bader M
    Hypertension; 2008 Nov; 52(5):967-73. PubMed ID: 18809792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis.
    Zhang YH; Hao QQ; Wang XY; Chen X; Wang N; Zhu L; Li SY; Yu QT; Dong B
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):292-300. PubMed ID: 25070352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.
    Fraga-Silva RA; Montecucco F; Costa-Fraga FP; Nencioni A; Caffa I; Bragina ME; Mach F; Raizada MK; Santos RAS; da Silva RF; Stergiopulos N
    Vascul Pharmacol; 2015 Nov; 74():103-113. PubMed ID: 26304699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors.
    Wang L; de Kloet AD; Pati D; Hiller H; Smith JA; Pioquinto DJ; Ludin JA; Oh SP; Katovich MJ; Frazier CJ; Raizada MK; Krause EG
    Neuropharmacology; 2016 Jun; 105():114-123. PubMed ID: 26767952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiatherosclerotic effects of the novel angiotensin receptor antagonist Fimasartan on plaque progression and stability in a rabbit model: a double-blind placebo-controlled trial.
    Lee JY; Lee CW; Kim WJ; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Son WC; Jung S; Park SW; Park SJ
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):229-36. PubMed ID: 23615162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
    Su Z; Zimpelmann J; Burns KD
    Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-localization of angiotensin-converting enzyme 2-, octomer-4- and CD34-positive cells in rabbit atherosclerotic plaques.
    Zulli A; Rai S; Buxton BF; Burrell LM; Hare DL
    Exp Physiol; 2008 May; 93(5):564-9. PubMed ID: 18192339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation.
    Feng Y; Yue X; Xia H; Bindom SM; Hickman PJ; Filipeanu CM; Wu G; Lazartigues E
    Circ Res; 2008 Mar; 102(6):729-36. PubMed ID: 18258853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-Converting Enzyme 2 Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice.
    Hao Q; Dong X; Chen X; Yan F; Wang X; Shi H; Dong B
    Hum Gene Ther; 2018 Dec; 29(12):1387-1395. PubMed ID: 28142259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.